S. Radhakrishnan

Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study

L. Rasche, C. Schinke, Anita D’Souza, 2024, Blood cancer journal.

Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma.

M. Zangari, F. van Rhee, B. Dhakal, 2024, Bone marrow transplantation.